Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
Member Alert: Virtual Hill Day 2014
Share |


Member Alert

Tuesday, May 6, 2014

IACP Sponsors Third Annual, “Virtual Hill Day”
Just Like Being There in Person Without the Travel!

On May 17-20, 2014, more than 400 compounding pharmacists and pharmacy technicians just like you will be gathered together for IACP’s 20th Annual Compounders on Capitol Hill conference in Washington, DC. On Tuesday, May 20th, your colleagues will be pounding the hallways of Congress, meeting with representatives and Senators to educate and secure their support of our legislative agenda.

But you’ve got a business to run. Patients to take care of. Prescriptions to compound, prepare and dispense. You can’t make it to Washington, DC this year.

And that’s okay. Because even if you’re not at Compounders on Capitol Hill in person, you can still add your voice along with those of pharmacists nationwide and make a real impact on legislation that can hurt or harm your business and your profession.

Once again, IACP is using technology to put you right there in those hallways and on the Capitol steps… at least virtually. Our unique Action Alert system lets you send a personalized, IACP-prepared request for support directly from your home or pharmacy straight to the offices of both your Representative and your Senator.

Watch your in-box on Monday, May 19, 2014 for information and links on how to send a message to Capitol Hill. It takes just a few minutes and can literally quadruple the number of compounding pharmacist voices ringing through the halls of Congress.

To give you some background on our legislative agenda this year, here’s a quick recap of our three, big issues along with the same 2014 Congressional Ask Documents that attendees at Compounders on Capitol Hill will see and take to the Hill in person.

Hold FDA Accountable to Congressional Intent in DQSA Implementation
  • FDA ignores Congressional intent by prohibiting all Office-Use Compounding in 503A
  • FDA continues down a path to ignore Congressional intent in implementing provisions on repackaging and the Memorandum of Understanding
  • FDA causes confusion for pharmacists and other stakeholders thru their letters sent to States and hospitals requesting they only do business with Outsourcing Facilities (OFs)
Require FDA to explain their rationale for ignoring Congressional intent; Require FDA to provide clear explanation to the medical and practice community; Obtain answers needed by the state legislatures and regulatory boards which find their laws in conflict with FDA interpretation.

For a complete background on this issue, click here to read the IACP-prepared 2014 Congressional Ask Document on “Hold FDA Accountable to Congressional Intent in DQSA Implementation.”

Restrict FDA Appropriations to Prevent the Agency’s Continued Disregard of Congressional Intent
  • FDA released its FY2015 budget request detailing how the President’s funding of $4.7 billion would be used in 2015
  • FDA plans to invest $25 million to “enhance compounding oversight activities in FY2015
  • FDA also has requested almost $7 million in additional funding for field activities including: “conducting additional inspections of high-risk human drug compounding pharmacies including sterile compounding facilities that seek to qualify for the section 503A exemptions and facilities that register as OFs under 503B.”
Support appropriations language that none of the funds made available in FY2015 budget may be used to prohibit the compounding of drug products under 503A of the Food, Drug, and Cosmetic Act when such compounding is permitted by state laws, regulations or rules.

For a complete background on this issue, click here to read the IACP prepared 2014 Congressional Ask Document on “Restrict FDA Appropriations to Prevent the Agency’s Continued Disregard of Congressional Intent.”

Support and Co-Sponsor H.R. 4069 – Ensuring Patient Access and Effective Drug Enforcement Act – with a Manager’s Amendment
  • The DEA does not permit a pharmacist to dispense a controlled substance to the patient’s doctor
  • There are medicines which should only be handled and managed by healthcare professionals to ensure stability and integrity.
  • The DEA has statutory authority to engage in rulemaking but has not done so despite repeated requests.
  • The DEA has informed organized pharmacy that it’s not willing to change its position despite a court opinion to the contrary, mounting evidence that there is resulting drug diversion, patient safety issues and drug shortage problems
Support and Co-Sponsor Congressman Marino (R-PA) and Congressman Blackburn (R-TN)’s H.R. 4069 with a Manager’s Amendment to enable a pharmacist to deliver a patient’s controlled substance to a prescriber.

For a complete background on this issue, click here to read the IACP prepared 2014 Congressional Ask Document on “Support and Co-Sponsor H.R. 4069.”

Want to learn more about being a successful advocate for compounding and your practice? IACP has a one-hour continuing education program that covers the ins and outs of preparing for and delivering a simple and clear message to legislators both on Capitol Hill and in your own district. Updated with brand new information this week, Being A Successful Compounding Advocate: Tips for Working with Your Legislators is now available in the IACP AdvanCE library of CE programs. To take the course, please click here.

In advance, IACP appreciates your help on these important issues. Should you need IACP staff to follow-up on any of the contacts you make, please don’t hesitate to let us know by contacting Cynthia Blankenship, ESQ., IACP’s Vice-President of Government Affairs at (703) 299-0796 or via e-mail at Your participation and efforts will help give the profession of compounding a stronger voice in Washington.

Stay connected to IACP by joining our online communities!

4638 Riverstone Blvd., Missouri City, TX 77459 | Phone: 281-933-8400 | Toll-Free Referral Line: 800-927-4227
Click here to unsubscribe.
© 2014 International Academy of Compounding Pharmacists. All Rights Reserved.




Association Management Software Powered by®  ::  Legal